About this trial
Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes. The traditional use of narcotics is challenging as the therapeutic window between analgesia and suppression of breathing becomes narrow with the intense pain and high doses of narcotics needed for dressing changes.
Eligibility criteria
Qualifiers
adult burn patients admitted to the Health Sciences Centre
total body surface area burned of 5-20%
Disqualifiers
admitted to intensive care unit
unable to participate in the measurement outcomes (sedated, cognitively impaired, unable to understand English or visually impaired)
medical condition that precludes using nitrous oxide (respiratory disease and significant cardiovascular disease 5).
pregnant
Trial design
Treatments tested in this trial
- Nitrous Oxide Inhalant Product
- Placebo